This inventor holds 7 USPTO granted patents and 8 published patent applications, plus 4 CIPO patents and 2 EPO patents. Top assignee: Medtronic Minimed, Inc.. Active years: 2013-2026.
Company Filing History:
Years Active: 2013-2026
Title: Qingling Yang: Innovator in Glucose Sensor Technology
Introduction
Qingling Yang is a prominent inventor based in Northridge, CA (US), known for her significant contributions to the field of glucose sensor technology. With a total of 7 patents to her name, she has made remarkable advancements that aid in the management of diabetes.
Latest Patents
One of her latest patents is titled "Interference rejection membranes comprising crosslinked poly (vinyl alcohol) matrices for implantable glucose sensors." This invention provides amperometric analyte sensors that feature optimized elements, including interference rejection membranes. The membranes are made from poly(vinyl alcohol) (PVA) polymers that are crosslinked by an acid crosslinker, enhancing the functionality of glucose sensors. Another notable patent is "Enzyme mediator functionalized polymers for use with analyte sensors." This invention focuses on optimizing enzymatic activities in amperometric analyte sensors, particularly for glucose or ketone sensors used in diabetes management.
Career Highlights
Qingling Yang currently works at Medtronic Minimed, Inc., where she continues to innovate in the field of medical technology. Her work has been instrumental in developing advanced sensor technologies that improve patient outcomes.
Collaborations
Throughout her career, Qingling has collaborated with notable colleagues, including Rajiv Shah and Ashwin K Rao, contributing to a dynamic and innovative work environment.
Conclusion
Qingling Yang's contributions to glucose sensor technology exemplify her dedication to improving healthcare solutions. Her innovative patents and collaborative efforts position her as a leading figure in the field.